Introduction {#sec1}
============

In December 2019, a new cluster of pneumonia was reported in Wuhan, China, which was linked to a novel coronavirus on January 7th, 2020.[@bib1] This severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spread rapidly, and on January 30^th^, the World Health Organization declared a public health emergency of international concern.[@bib2] In the Netherlands, the first infection was confirmed on February 27th, 2020. A week later, on March 3rd, the first patient tested positive at our hospital. In the following days, the number of infections increased, which led to an intelligent lockdown on March 16th, 2020. At that moment, 184 patients with SARS-CoV-2 infection were admitted to the hospital in the Netherlands.[@bib3] The pandemic continued despite all measurements taken, and within 3 weeks' time, 1,314 patients with SARS-CoV-2 infection were admitted to the intensive care unit in the Netherlands.[@bib4] Our hospital is situated in one of the regions in the Netherlands that was most affected by the novel coronavirus.[@bib3]

Owing to the increasing number of coronavirus disease 2019 (COVID-19) infections and hospital admissions, there was a shift from providing regular health care toward urgent services only. Most outpatient and primary care physician (PCP) visits were minimized, and consults were mainly performed by phone. Physical examinations were reduced significantly, which may have led to delays in diagnosis and treatment of patients without COVID-19. In line with this, Sena and Galleli (2020)[@bib5] describe a significantly greater number of amputations performed in their surgery department during the COVID-19 lockdown in Italy. In our clinic, all elective surgeries were postponed; only urgent surgical care was delivered. Patients with clinical symptoms of COVID-19 underwent testing by nasopharyngeal swab or computed tomography scan of the thorax. There was a separate operating theater for patients undergoing surgery who tested positive or with high clinical suspicion. The aim of our study is to investigate the effect of the intelligent lockdown in the Netherlands on all major vascular surgery procedures performed in the operating theater of our hospital.

During the COVID-19 pandemic, new guidelines were introduced to prioritize patients for surgical intervention.[@bib6] Patients suffering from peripheral arterial disease with severe limb ischemia (Rutherford grade 4 or higher) and patients with an aortic aneurysm \> 7.0 cm were classified as urgent.[@bib7] Therefore, in this article, we focus on patients undergoing urgent surgical intervention for either limb ischemia (acute or chronic) or an aortic aneurysm.

Methods {#sec2}
=======

Patient Characteristics {#sec2.1}
-----------------------

All patients who underwent vascular surgery for peripheral arterial disease or an aortic aneurysm during the COVID-19 intelligent lockdown period (March 16, 2020--April 30, 2020) at the Amphia hospital in Breda, the Netherlands, were included in this study. The control group consisted of all patients who underwent vascular surgery in the same period in 2019 and 2018. Patient characteristics including the age, gender, and comorbidities were retrieved from electronic medical records. If patients underwent multiple interventions during the study period, we documented them as separate records linked to one patient. The COVID-19 status was determined on either nasopharyngeal swab or imaging of the thorax.

For patients with chronic peripheral arterial occlusive disease, the Rutherford classification system was used to record the extent of the disease.[@bib7] Rutherford V (minor tissue loss) and VI (major tissue loss) were classified as one category (tissue loss) because categorizing the difference between both categories retrospectively from patient records could not be performed objectively.

Our research was approved by the local review board of the Amphia Hospital.

Outcome Measurements {#sec2.2}
--------------------

The primary outcome measures were the number and type of procedures performed. Surgical procedures were either related to limb ischemia or abdominal aortic aneurysm repair. Amputations were divided in two different categories. Major limb amputation was defined as an amputation above the level of the ankle.[@bib8] Amputations of the foot or digiti were classified as minor limb amputations.

Statistical Analysis {#sec2.3}
--------------------

Descriptive statistics were used to present baseline characteristics and outcome measures. Categorical variables are presented as numbers with percentages. Continuous variables are presented as means with range. The chi-squared test was used to test for significant differences between categorical variables. A Bonferroni correction was performed for the chi-squared tests to correct for multiple testing. For continuous variables, an analysis of variance test was performed for multiple testing. Data were analyzed using SPSS Statistics.

Results {#sec3}
=======

Patient Characteristics {#sec3.1}
-----------------------

In total, 38 patients underwent vascular surgery during the COVID-19 lockdown period, compared with 29 patients during the same period in 2019 and 54 in 2018. The baseline characteristics of all patients are presented in [Table I](#tbl1){ref-type="table"} . There were no statistically significant differences between the groups at baseline. In the population of 2020, only 2 of the 38 patients tested positive for COVID-19.Table IPatient characteristicsParameters202020192018*P*-value[a](#tbl1fna){ref-type="table-fn"}*n* = 38*n* = 29*n* = 54Age (mean; range)71 (30--86)69 (53--88)70 (49--90)0.635Sex0.485 Female12 (32)7 (24)20 (37) Male26 (68)22 (76)34 (63)BMI (mean; range)25.8 (18.2--38.6)24.2 (16.5--30.9)24.9 (15.6--33.8)0.546Smoking status0.061 Active27 (71)17 (59)40 (74) Never10 (26)5 (17)10 (19) Unknown1 (3)7 (24)4 (7)Comorbidities Diabetes10 (26)10 (35)13 (24)0.694 Hypertension30 (79)18 (62)43 (80)0.260 Hypercholesterolemia26 (68)14 (48)34 (63)0.315 Coronary artery disease8 (21)10 (34)17 (31)0.416 Atrial fibrillation10 (26)5 (17)14 (26)0.622 Chronic obstructive pulmonary disease9 (24)7 (24)15 (28)0.887 Obstructive sleep apnea1 (3)2 (7)4 (7)0.601 History of stroke3 (8)6 (21)10 (19)0.270History of vascular surgery Minor amputation3 (8)3 (10)3 (6)0.724 Major amputation1 (3)3 (10)4 (7)0.431 Aneurysm surgery3 (8)0 (0)2 (4)0.268 Peripheral vascular surgery21 (55)12 (41)21 (39)0.375Positive COVID-19 status2 (5)Diagnosis10 (26)7 (24)15 (28)0.848 Aortic aneurysm19 (50)17 (59)31 (57) Chronic limb ischemia5 (13)4 (14)6 (11) Acute embolus4 (11)1 (3)2 (4) Other[^1][^2][^3]

Peripheral Arterial Obstructive Disease {#sec3.2}
---------------------------------------

During the lockdown period in 2020, 19 patients with peripheral arterial obstructive disease underwent surgery for chronic limb ischemia. We observed a statistically significant difference in the degree of tissue loss as categorized by the Rutherford classification in these patients compared with the control groups ([Table II](#tbl2){ref-type="table"} ). The number of patients presenting with Rutherford grade V/VI (90%) was significantly higher during the lockdown period, whereas the number of patients presenting with Rutherford grade III (5%) peripheral arterial occlusive disease was significantly lower (*P*-value = 0.007). There was no significant difference in the number of patients presenting with ischemia due to a diabetic foot ([Table III](#tbl3){ref-type="table"} ) or acute limb ischemia ([Table I](#tbl1){ref-type="table"}).Table IIPresentation of patients with chronic limb ischemiaParameters202020192018*P*-value[a](#tbl2fna){ref-type="table-fn"}n = 19*n* = 17*n* = 31Rutherford classification0.007[b](#tbl2fnb){ref-type="table-fn"} Grade I1 (3) Grade II1 (6)6 (19) Grade III1 (5)[c](#tbl2fnc){ref-type="table-fn"}5 (29)[c](#tbl2fnc){ref-type="table-fn"}1 (3) Grade IV1 (5)4 (24)8 (26) Grade V and VI17 (90)[d](#tbl2fnd){ref-type="table-fn"}7 (41)15 (48)Diabetic foot present3250.914[^4][^5][^6][^7][^8]Table IIIVascular surgical interventionsIntervention202020192018*P*-value[a](#tbl3fna){ref-type="table-fn"}n = 36*n* = 28*n* = 51Minor amputations3 (11)1 (2)0.019[b](#tbl3fnb){ref-type="table-fn"}Major amputations15 (42)[c](#tbl3fnc){ref-type="table-fn"}5 (18)8 (15)[c](#tbl3fnc){ref-type="table-fn"}Bypass surgery9 (25)7 (25)11 (21)Endarterectomy1 (3)[c](#tbl3fnc){ref-type="table-fn"}5 (18)13 (24)[c](#tbl3fnc){ref-type="table-fn"}Embolectomy6 (16)6 (21)10 (19)Other5 (14)2 (7)10 (19)[^9][^10][^11][^12]

Surgical Interventions for Limb Ischemia {#sec3.3}
----------------------------------------

Vascular interventions for critical limb ischemia (chronic or acute) are focused on either revascularization of the limb or removal of ischemic necrotic tissue. During the 2020 lockdown period, 36 surgical peripheral vascular interventions were performed ([Table III](#tbl3){ref-type="table"}). The type of surgery performed during this period differed significantly from the type of surgery performed during the previous years (*P*-value = 0.019). Significantly more major amputations (15 (42%) in 2020, 5 (18%) in 2019, and 8 (15%) in 2018) were performed during the lockdown period in 2020 and significantly less endarterectomies than those in the same period in 2018 ([Table III](#tbl3){ref-type="table"}). Of all major amputations performed in our study population, only two were performed for acute limb ischemia, both in the 2020 cohort (2/15).

Aortic Aneurysm {#sec3.4}
---------------

During the COVID-19 lockdown period, 10 patients underwent surgery for an aortic aneurysm. We observed no differences for aortic surgery in the different periods ([Table IV](#tbl4){ref-type="table"} ).Table IVPresentation and treatment of patients with an aortic aneurysmParameters202020192018*P*-value[a](#tbl4fna){ref-type="table-fn"}n = 10*n* = 7*n* = 15Aortic aneurysm0.582 Asymptomatic5 (50)6 (86)11 (73) Symptomatic3 (30)01 (7) Ruptured2 (20)1 (14)3 (20)Diameter of the aortic aneurysm72.1 (58--110)59.9 (52--78)64.2 (43--93)0.175Endovascular aortic reconstruction5 (50)6 (86)6 (40)0.131Open reconstruction5 (50)1 (14)9 (60)[^13][^14]

Discussion {#sec4}
==========

This study shows that during the COVID-19 lockdown period, there was a significant difference in the number and type of peripheral vascular surgeries performed. More major amputations (15 (42%) in 2020, 5 (18%) in 2019, and 8 (15%) in 2018) were performed, whereas the number of endarterectomies was significantly less. Major amputation leads to severe morbidity and is associated with a high 1-year mortality rate of 44%.[@bib9] Moreover, patients with chronic limb ischemia who underwent surgery presented with a higher Rutherford grade of ischemic damage. We observed no difference in vascular surgical care for patients with an aortic aneurysm.

There are several limitations of this study. First, this was a retrospective study. Second, owing to the nature of our research question and the short period of the intelligent lockdown in the Netherlands, the number of patients and surgical interventions is small. However, Sena and Galleli (2020) describe the same findings in their study during the lockdown period in Italy.[@bib5] They report 9 amputations during the lockdown period in 2020 compared with 5 amputations in 2019.[@bib5] We recommend further investigation of the reported effects in a multicenter study.

In our study population, COVID-19 itself and its hypercoagulable state do not seem to play a major role in the differences observed because only two patients tested positive for SARS-CoV-2.[@bib10] One possible explanation for the observed differences is that the usual standard of care delivered by PCP services and outpatient clinics was minimized or even absent. Most visits were replaced by phone or video consults. Wounds related to ischemic damage of patients with peripheral arterial occlusive disease were therefore possibly not cared for sufficiently. Patient delay may also have been an important factor, with patients being afraid to get infected when visiting a physician. Moreover, patient delay may also have occurred if patients felt they would have been a burden to health-care professionals dealing with patients with COVID-19. It can be hypothesized that COVID-19 did play a role in the increased number of amputations because of false-negative results of the nasopharyngeal swap.[@bib11] In our study population, no changes were made in anticoagulant therapy for patients with peripheral arterial occlusive disease during the lockdown period.

Patients with limb ischemia are a fragile and vulnerable group of patients[@bib12] whose outcomes are negatively affected if the usual standard of care is delayed. It is therefore important that during a future pandemic, regular medical care should continue for these patients, with caregivers being aware of these patients and referring in time for revascularization. The increased number of major limb amputations seen in this study may have a large impact on the functional outcome, quality of life, and should thus be prevented.[@bib13] Finally, although social distancing is critical for eliminating the spread of the SARS-CoV-2 virus, patients should not have to be afraid to visit their physician. An accurate assessment of wounds and tissue loss is essential in these patients, through either high-quality electronic video or photo consultation or physical examination.

Conclusion {#sec5}
==========

The measurements taken during the COVID-19 lockdown period have had a significant effect on non--COVID-19 vascular patient care. This has resulted in an increase in the number of major amputations, leading to more severe morbidity. Policy makers and physicians should be aware of the impact on vulnerable patients, such as those with peripheral arterial occlusive disease. For these patients, medical care should be easily accessible and adequate during a future pandemic.
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[^1]: Values are numbers (percentages) unless stated otherwise.

[^2]: BMI, body mass index; ANOVA, analysis of variance.

[^3]: Chi-squared test with the Bonferroni correction for categorical variables; the ANOVA test for continuous variables.

[^4]: Values are numbers (percentages) unless stated otherwise.

[^5]: Chi-squared test with the Bonferroni correction.

[^6]: *P*-value \<.05.

[^7]: Statistically significant difference between the observed number of patients in 2020 and 2019.

[^8]: The observed number of patients in 2020 differs significantly from 2019 to 2018.

[^9]: Values are numbers (percentages) unless stated otherwise.

[^10]: Chi-squared test with the Bonferroni correction.

[^11]: *P*-value \<.05.

[^12]: Statistically significant difference between the observed numbers 2020 and 2018.

[^13]: Values are numbers (percentages) unless stated otherwise.

[^14]: Chi-squared test with the Bonferroni correction.
